Heat-shock protein vaccines as active immunotherapy against human gliomas
/in Dendritic Cells, Glioblastoma, Hyperthermia, International Publications /von 2009-11-01 / Expert Rev Anticancer Ther 2009 Nov;9(11):1577-82Partial T cell-depleted allogeneic stem cell transplantation following reduced-intensity conditioning creates a platform for immunotherapy with donor lymphocyte infusion and recipient dendritic cell vaccination in multiple myeloma
/in Dendritic Cells, International Publications, Multiple Myeloma /von 2009-10-14 / Biol. Blood Marrow Transplant. 2010 Mar;16(3):320-32Dendritic cell-based cancer gene therapy
/in Dendritic Cells, International Publications /von 2009-10-01 / Hum. Gene Ther. 2009 Oct;20(10):1106-18Immunizing against breast cancer: a new swing for an old sword
/in Breast Cancer, Dendritic Cells, International Publications /von 2009-10-01 / Breast 2009 Oct;18 Suppl 3:S51-4Immunotherapy with dendritic cells pulsed by autologous dactinomycin-induced melanoma apoptotic bodies for patients with malignant melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2009-10-01 / Melanoma Res. 2009 Oct;19(5):309-15Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma
/in Checkpoint-Inhibitors, Dendritic Cells, International Publications, Malignant Melanoma /von 2009-09-29 / Clin. Cancer Res. 2009 Oct;15(19):6267-76Abrogation of local cancer recurrence after radiofrequency ablation by dendritic cell-based hyperthermic tumor vaccine
/in Dendritic Cells, Hyperthermia, International Publications /von 2009-09-22 / Mol. Ther. 2009 Dec;17(12):2049-57Enhanced T-cell activation by immature dendritic cells loaded with HSP70-expressing heat-killed melanoma cells
/in Dendritic Cells, Hyperthermia, International Publications /von 2009-09-15 / Exp. Dermatol. 2010 Feb;19(2):108-16Therapeutic and tumor-specific immunity induced by combination of dendritic cells and oncolytic adenovirus expressing IL-12 and 4-1BBL
/in Dendritic Cells, International Publications /von 2009-09-08 / Mol. Ther. 2010 Feb;18(2):264-74
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Das IOZK
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- Recent developments in targeting breast cancer stem cells (BCSCs): a descriptive review of therapeutic strategies and emerging therapies
- Neoantigen-targeted dendritic cell vaccination in lung cancer patients induces long-lived T cells exhibiting the full differentiation spectrum
- Individualized Multimodal Immunotherapy (IMI): Scientific Rationale and Clinical Experience from a Single Institution